Literature DB >> 20443812

Clinical and translational sciences: at the intersection of molecular and individualized medicine.

Scott A Waldman1, Andre Terzic.   

Abstract

Mesh：

Year:  2008        PMID： 20443812      PMCID： PMC5439587          DOI： 10.1111/j.1752-8062.2008.00019.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  17 in total

Review 1.  The prospects for "personalized medicine" in drug development and drug therapy.

Authors:  J Woodcock
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

Review 2.  The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors:  K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

3.  The art and science of personalized medicine.

Authors:  M Piquette-Miller; D M Grant
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

4.  A vision of individualized medicine in the context of global health.

Authors:  D A Cortese
Journal:  Clin Pharmacol Ther       Date:  2007-11       Impact factor: 6.875

Review 5.  New programs for gene- and cell-based therapies at NHLBI.

Authors:  S I Skarlatos
Journal:  Clin Pharmacol Ther       Date:  2007-07-11       Impact factor: 6.875

Review 6.  Embryonic stem cells: from bench to bedside.

Authors:  M Pucéat; A Ballis
Journal:  Clin Pharmacol Ther       Date:  2007-07-18       Impact factor: 6.875

7.  Personalized medicine: elusive dream or imminent reality?

Authors:  L J Lesko
Journal:  Clin Pharmacol Ther       Date:  2007-06       Impact factor: 6.875

8.  Translating MicroRNA discovery into clinical biomarkers in cancer.

Authors:  Scott A Waldman; Andre Terzic
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

9.  Acquired and innate cardioprotection.

Authors:  Andre Terzic; Russell L Moore; Scott A Waldman
Journal:  J Appl Physiol (1985)       Date:  2007-08-09

10.  Molecular medicine hones therapeutic arts to science.

Authors:  S A Waldman; M R Terzic; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-10       Impact factor: 6.875
View more
  6 in total

Review 1.  Widening the path to personalized medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

2.  From research to public policy: an essential extension of the translation research agenda.

Authors:  David M Mirvis
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

3.  Translational medicine in the era of health care reform.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

4.  Clinical and translational science: from bench-bedside to global village.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

5.  The value proposition of molecular medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

6.  Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.

Authors:  Timothy J Nelson; Atta Behfar; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.